This is a preview of subscription content, log in via an institution to check access.
Reference
Verhoef T, et al. Cost-Effectiveness of Pharmacogenetic-Guided Dosing of Phenprocoumon in Atrial Fibrillation. 29th International Conference on Pharmacoepidemiology and Therapeutic Risk Management : abstr. 657, 25 Aug 2013. Available from: URL: http://www.abstracts2view.com/ispe/view.php?nu=ISPE13L1%5f16
Rights and permissions
About this article
Cite this article
Genetic typing for phenprocoumon dosing likely to be worth it?. PharmacoEcon Outcomes News 686, 7 (2013). https://doi.org/10.1007/s40274-013-0684-z
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-013-0684-z